L. C. Coates
C. T. Ritchlin
L. Gossec
P. Helliwell
P. Rahman
E. C. Hsia
A. Kollmeier
X. L. Xu
C. Karyekar
M. Shawi
W. Noel
Y. Jiang
S. Sheng
Y. Wang
P. J. Mease
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom
University of Rochester, Allergy/Immunology and Rheumatology, Rochester, United States of America
Sorbonne Université, Rheumatology, Paris, France
University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom
Memorial University of Newfoundland, Craig L Dobbin Genetics Research Centre, St John’s, Canada
Janssen Research & Development, Raritan, United States of America
University of Pennsylvania School of Medicine, Immunology, Philadelphia, United States of America
Janssen Research & Development, Immunology, Philadelphia, United States of America
, Janssen Global Services, LLC, Horsham, PA, United States of America
Janssen Scientific Affairs, LLC, Immunology, Brussels, Belgium
Janssen Research & Development, Raritan, United States of America
2Swedish Medical Center/Providence St. Joseph Health and University of Washington, Rheumatology, Seattle, Washington, United States of America
United Kingdom
United States
France
Canada
Belgium
N/A
Musculoskeletal
Dermatology
Psoriatic arthritis
C reactive protein
Malondialdehyde
guselkumab (IV)
N/A
Randomized
Placebo Control
III
N/A
Abbvie
N/A